Subscribe to Newsletter

Retina

Subspecialties Retina

‘Un-eclipsing’ Solar Harm

| Ruth Steer

AO-SLO imaging reveals the retinal damage caused by staring at the sun.
Subspecialties Retina

Artificial Win(telligence)

| Ruth Steer

Can a deep learning system really equal professional human graders in detecting retinal diseases?
Subspecialties Retina

Peerless

| Mark Hillen

Can any other specialty match ophthalmology when it comes to pushing medicine forwards?
Subspecialties Business and Innovation

Sustaining Innovation

| Michael O’Rourke

Sustained-release drug delivery technologies over time, and how future innovators should proceed…
Subspecialties Retina

Jury’s Out

| David A. Eichenbaum

Placing the HAWK/HARRIER data in the wider context of nAMD anti-VEGF trial data.
Subspecialties Retina

A Whole New World

| Jesse Berry

It shouldn't be about epi-on or epi-off CXL… The focus should be on what's best for patients.
Subspecialties Retina

Quite a Stretch

| Mark Hillen

Can brolucizumab extend the AMD anti-VEGF treatment interval?
Subspecialties Retina

Red Light Means Go?

| Ruth Steer

A recent trial shows promise for a new ocular melanoma therapeutic.
Subspecialties Retina

How Low Can You Go?

| Ruth Steer

Optimizing ROP treatment by scaling back the dose.
Subspecialties Retina

A New Dry AMD Target?

| Ruth Steer

A US research team have identified a novel enzyme that appears to play a role in disease progression.
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

December Issue of The Ophthalmologist
Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: